Search research articles
Contact Us
Filters
Showing results (11-20 of 1,469) with videos related to
Page
of 147
Sort By:
Neurodegenerative Disease Management
|
December 17, 2021
GOCOVRI<sup>®</sup> (amantadine) extended-release capsules in Parkinson's disease
Thomas Müller
MMW Fortschritte Der Medizin
|
August 28, 2025
Thomas Müller
MMW Fortschritte Der Medizin
|
August 28, 2025
Thomas Müller
MMW Fortschritte Der Medizin
|
May 15, 2020
Thomas Müller
MMW Fortschritte Der Medizin
|
May 25, 2020
Thomas Müller
CME (Berlin, Germany)
|
June 15, 2021
Thomas Müller
MMW Fortschritte Der Medizin
|
November 16, 2023
Thomas Müller
Medizinhistorisches Journal
|
July 1, 2004
[Comparison and transfer analysis in the History of Medicine? A discussion using travelelogues as a source]
Thomas Müller
Gesnerus
|
March 20, 2004
[From Basel to Bad Nassau. The fate of the psychoanalyst Arthur Muthmann (1875-1957)]
Thomas Müller
Patient Preference and Adherence
|
November 26, 2009
Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference
Thomas Müller
Page
of 147
Search research articles
Search
Showing results (11-20 of 1,469) with videos related to
Sort By:
Page
of 147
Neurodegenerative Disease Management
|
December 17, 2021
GOCOVRI<sup>®</sup> (amantadine) extended-release capsules in Parkinson's disease
Thomas Müller
MMW Fortschritte Der Medizin
|
August 28, 2025
Thomas Müller
MMW Fortschritte Der Medizin
|
August 28, 2025
Thomas Müller
MMW Fortschritte Der Medizin
|
May 15, 2020
Thomas Müller
MMW Fortschritte Der Medizin
|
May 25, 2020
Thomas Müller
CME (Berlin, Germany)
|
June 15, 2021
Thomas Müller
MMW Fortschritte Der Medizin
|
November 16, 2023
Thomas Müller
Medizinhistorisches Journal
|
July 1, 2004
[Comparison and transfer analysis in the History of Medicine? A discussion using travelelogues as a source]
Thomas Müller
Gesnerus
|
March 20, 2004
[From Basel to Bad Nassau. The fate of the psychoanalyst Arthur Muthmann (1875-1957)]
Thomas Müller
Patient Preference and Adherence
|
November 26, 2009
Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference
Thomas Müller
Page
of 147